ARTICLE | Clinical News
IV finafloxacin: Phase II started
December 17, 2012 8:00 AM UTC
MerLion began a double-blind, double-dummy, European Phase II trial to compare 3.2 mg/mL IV finafloxacin and 200 mg oral finafloxacin for 5 or 10 days vs. oral and IV ciprofloxacin for 10 days in up to 258 patients. The oral formulation of finafloxacin has completed Phase IIa testing to treat urinary tract and Helicobacter pylori infections, while IV finafloxacin completed a Phase I trial last month. A topical formulation of finafloxacin is in Phase III testing to treat acute otitis externa. ...